Financhill
Buy
65

KCLI Quote, Financials, Valuation and Earnings

Last price:
$32.25
Seasonality move :
1.43%
Day range:
$32.25 - $32.25
52-week range:
$27.45 - $36.67
Dividend yield:
1.74%
P/E ratio:
5.88x
P/S ratio:
0.65x
P/B ratio:
0.51x
Volume:
--
Avg. volume:
1.5K
1-year change:
-10.42%
Market cap:
$312.3M
Revenue:
$490.8M
EPS (TTM):
-$3.68

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Kansas City Life Insurance Co. has -- downside to fair value with a price target of -- per share.

KCLI vs. S&P 500

  • Over the past 5 trading days, Kansas City Life Insurance Co. has overperformed the S&P 500 by 0.01% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Kansas City Life Insurance Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Kansas City Life Insurance Co. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Kansas City Life Insurance Co. reported revenues of $123.8M.

Earnings Growth

  • Kansas City Life Insurance Co. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Kansas City Life Insurance Co. reported earnings per share of $0.33.
Enterprise value:
312.3M
EV / Invested capital:
--
Price / LTM sales:
0.65x
EV / EBIT:
1.23x
EV / Revenue:
0.65x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.67x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-0.77%
Net Income Margin (TTM):
-7.41%
Return On Equity:
-5.88%
Return On Invested Capital:
-5.88%
Operating Margin:
3.22%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $495.4M $497.4M $480.9M $125.1M $123.8M
Gross Profit -- -- -- -- --
Operating Income -$14.3M $7.6M -$49.9M $1.7M $4M
EBITDA -- -- -- -- --
Diluted EPS -$1.19 $5.86 -$3.68 $0.14 $0.33
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $220.3M $171.7M $162.2M $179.2M $195.3M
Total Assets $5B $4.6B $4.5B $4.7B $4.6B
Current Liabilities -$321.8M -$326M -$353.1M -$350.7M -$356.5M
Total Liabilities $4.2B $4.1B $4B $4B $4B
Total Equity $835.8M $497.8M $448.3M $652.9M $608.8M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$64.7M -$55.6M -$116.8M -$10.6M -$20.3M
Cash From Investing -$52K -$8.1M $34.4M -$15M $6.3M
Cash From Financing $65.7M $63.1M $84.2M $25.8M $15.4M
Free Cash Flow -$65.8M -$56.7M -$117.1M -$11.5M -$20.3M
KCLI
Sector
Market Cap
$312.3M
$566.8M
Price % of 52-Week High
87.95%
92.6%
Dividend Yield
1.74%
1.57%
Shareholder Yield
1.74%
3.13%
1-Year Price Total Return
-10.42%
8.67%
Beta (5-Year)
0.453
0.479
Dividend yield:
1.74%
Annualized payout:
$0.56
Payout ratio:
43.01%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $32.10
200-day SMA
Buy
Level $31.64
Bollinger Bands (100)
Sell
Level 31.05 - 34.09
Chaikin Money Flow
Sell
Level -913.7K
20-day SMA
Buy
Level $31.79
Relative Strength Index (RSI14)
Buy
Level 57.38
ADX Line
Buy
Level 21.45
Williams %R
Neutral
Level -30
50-day SMA
Buy
Level $31.54
MACD (12, 26)
Buy
Level 0.16
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Neutral
Level 731.7K

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.5887)
Sell
CA Score (Annual)
Level (-2.1355)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-4.2819)
Sell
Piotroski F Score (Annual)
Level (1)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Kansas City Life Insurance Co. engages in the provision of financial protection through the sale of life insurance and annuities. It operates through the following business segments: Individual Insurance, Group Insurance, and Old American. The Individual Insurance segment includes individual insurance products for Kansas City Life, Sunset Life, and Grange Life, and the assumed reinsurance transactions. The Group Insurance segment consists of sales group life, dental, vision, and group disability products. The Old American segment covers individual insurance products designed as final expense products. The company was founded by J. H. North, S. E. Rumble, and William Warner on May 1,1895 and is headquartered in Kansas City, MO.

Stock Forecast FAQ

In the current month, KCLI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KCLI average analyst price target in the past 3 months is --.

  • Where Will Kansas City Life Insurance Co. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Kansas City Life Insurance Co. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Kansas City Life Insurance Co.?

    Analysts are divided on their view about Kansas City Life Insurance Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kansas City Life Insurance Co. is a Sell and believe this share price will rise from its current level to --.

  • What Is Kansas City Life Insurance Co.'s Price Target?

    The price target for Kansas City Life Insurance Co. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is KCLI A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Kansas City Life Insurance Co. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of KCLI?

    You can purchase shares of Kansas City Life Insurance Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kansas City Life Insurance Co. shares.

  • What Is The Kansas City Life Insurance Co. Share Price Today?

    Kansas City Life Insurance Co. was last trading at $32.25 per share. This represents the most recent stock quote for Kansas City Life Insurance Co.. Yesterday, Kansas City Life Insurance Co. closed at $32.25 per share.

  • How To Buy Kansas City Life Insurance Co. Stock Online?

    In order to purchase Kansas City Life Insurance Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock